Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Czeizel-Losonci syndrome (CLS) is an exceedingly rare, severe, congenital genetic malformation disorder characterized by split hand/split foot, hydronephrosis, and spina bifida. Spinal and skeletal manifestations were thoracolumbar scoliosis, spinabifida (spina bifida occulta or spina bifida cystic), Bochdalek diaphragmatic hernia, and radial defects.There have been no further descriptions in the literature since 1987.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Czeizel-Losonci syndrome.
3 publications have been identified in PubMed for Czeizel-Losonci syndrome. Research spans Other (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
Saleem ES (2026). [PMID: 41952705](https://pubmed.ncbi.nlm.nih.gov/41952705/). *Surg Neurol Int*. [Case Report / Case Series]
Karaaslan B (2024). [PMID: 35132932](https://pubmed.ncbi.nlm.nih.gov/35132932/). *Br J Neurosurg*. [Other]
Sergeenko OM (2024). [PMID: 38441629](https://pubmed.ncbi.nlm.nih.gov/38441629/). *Childs Nerv Syst*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:48 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Czeizel-Losonci syndrome